QQ客服 官方微博 反馈留言

	Association of CCL2, CCR2 and CCL5 genetic polymorphisms with the development and progression of benign prostatic hyperplasia.
	Yangyang Pang; Haoran Li; Yuwen Gong; Suoshi Jing; Cheng Peng; Wei Liu; Youli Zhao; Hanzhang Wang; Dharam Kaushik; Ronald Rodriguez
刊名	Oncology reports
	2019
ISSN号	1791-2431
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4744008
专题	湖南大学
作者单位	Institute of Urology, Lanzhou University Second Hospital, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro-Urological Clinical Center, Lanzhou, Gansu 730030, P.R. China. Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, P.R. China. Department of Urology, University of Texas Health Science Center San Antonio, San Antonio, TX 78229, USA.
推荐引用方式 GB/T 7714	Yangyang Pang,Haoran Li,Yuwen Gong,et al. Association of CCL2, CCR2 and CCL5 genetic polymorphisms with the development and progression of benign prostatic hyperplasia.[J]. Oncology reports,2019.
APA	Yangyang Pang.,Haoran Li.,Yuwen Gong.,Suoshi Jing.,Cheng Peng.,...&Zhiping Wang.(2019).Association of CCL2, CCR2 and CCL5 genetic polymorphisms with the development and progression of benign prostatic hyperplasia..Oncology reports.
MLA	Yangyang Pang,et al."Association of CCL2, CCR2 and CCL5 genetic polymorphisms with the development and progression of benign prostatic hyperplasia.".Oncology reports (2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。